Acute Treatment for MigraineJAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for MigraineNEJM 381:142-149, Lipton, R.B.,et al, 2019